Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / *W EXP 08/28/203
-
Total 13F shares
-
5,170,496
-
Share change
-
+194,928
-
Total reported value
-
$5,119,255
-
Price per share
-
$0.99
-
Number of holders
-
11
-
Value change
-
+$172,306
-
Number of buys
-
6
-
Number of sells
-
2
Institutional Holders of YD Bio Ltd - *W EXP 08/28/203 (YDESW) as of Q4 2025
As of 31 Dec 2025,
YD Bio Ltd - *W EXP 08/28/203 (YDESW) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,170,496 shares.
The largest 10 holders included
Cypress Capital Management LLC (WY), Cerity Partners LLC, True North Advisors, LLC, Clear Street Group Inc., Merit Financial Group, LLC, Concurrent Investment Advisors, LLC, T3 Companies, LLC, ARISTEIA CAPITAL, L.L.C., BANK OF AMERICA CORP /DE/, and UBS Group AG.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.